Comparison of Laparoscopic Myomectomy in Large Myomas With and Without Leuprolide Acetate

Wen Chun Chang, Ling Hui Chu, Pei Shen Huang, Su Cheng Huang, Bor Ching Sheu

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Objective: To evaluate the efficacy of gonadotropin-releasing hormone analogue (GnRHa) use before laparoscopic myomectomy (LM) in large myomas. Design: Prospective study (Canadian Task Force classification II-1). Setting: University-affiliated hospital. Patients: Ninety-one women with large myomas (≥10 cm) or more than 2 myomas ≥ 5 cm underwent LM between July 2011 and March 2014. Interventions: Forty patients underwent LM after GnRHa use (group A) and 51 underwent LM only (group B). GnRHa was used for 3 doses every 4 weeks before LM in group A. Measurements and Main Results: Group A had a significantly smaller maximum diameter of the largest myoma than group B (8.5 ± 2.1 vs 10.7 ± 2.4, p <.001) and fewer patients with myomas larger than 10 cm after GnRHa administration (33% vs 67%, p =.001). In group A, there was a decrease in 2 or more myomas ≥ 5 cm (20% vs 50%) after GnRHa use. Group A also had significantly smaller mean myoma weight (448 vs 567 g, p =.045) and significantly shorter mean operative time (129 ± 30 vs 152 ± 34 minutes, p =.001). Most patients in group A (40%) had an operative time < 119 minutes, whereas most patients in group B (37%) had an operative time between 150 and 179 minutes. Group A also had less intraoperative blood loss (84 ± 53 vs 137 ± 166 mL, p <.001), drop in hemoglobin (1.5 ± 0.8 vs 3.0 ± 1.7 g/dl, p <.001), excessive bleeding (5% vs 33%, p =.001), postoperative hematoma (2.5% vs 9.8%, p =.168), and blood transfusion (7.5% vs 35%, p =.001). Conclusion: GnRHa before LM in large myomas may be an effective adjuvant treatment for women with large and multiple myomas. This method is beneficial in decreasing operative time, intraoperative bleeding, postoperative hemorrhage, and need of blood transfusion.

Original languageEnglish
Pages (from-to)992-996
Number of pages5
JournalJournal of Minimally Invasive Gynecology
Volume22
Issue number6
DOIs
Publication statusPublished - Jan 1 2015
Externally publishedYes

Fingerprint

Uterine Myomectomy
Leuprolide
Myoma
Gonadotropin-Releasing Hormone
Operative Time
Blood Transfusion
Hemorrhage
Postoperative Hemorrhage
Advisory Committees
Hematoma

Keywords

  • Gonadotropin-releasing hormone analogue
  • In situ morcellation
  • Laparoscopic myomectomy
  • Large myomas
  • Sarcoma

ASJC Scopus subject areas

  • Obstetrics and Gynaecology

Cite this

Comparison of Laparoscopic Myomectomy in Large Myomas With and Without Leuprolide Acetate. / Chang, Wen Chun; Chu, Ling Hui; Huang, Pei Shen; Huang, Su Cheng; Sheu, Bor Ching.

In: Journal of Minimally Invasive Gynecology, Vol. 22, No. 6, 01.01.2015, p. 992-996.

Research output: Contribution to journalArticle

@article{1c54158786604da09a1536525a102a11,
title = "Comparison of Laparoscopic Myomectomy in Large Myomas With and Without Leuprolide Acetate",
abstract = "Objective: To evaluate the efficacy of gonadotropin-releasing hormone analogue (GnRHa) use before laparoscopic myomectomy (LM) in large myomas. Design: Prospective study (Canadian Task Force classification II-1). Setting: University-affiliated hospital. Patients: Ninety-one women with large myomas (≥10 cm) or more than 2 myomas ≥ 5 cm underwent LM between July 2011 and March 2014. Interventions: Forty patients underwent LM after GnRHa use (group A) and 51 underwent LM only (group B). GnRHa was used for 3 doses every 4 weeks before LM in group A. Measurements and Main Results: Group A had a significantly smaller maximum diameter of the largest myoma than group B (8.5 ± 2.1 vs 10.7 ± 2.4, p <.001) and fewer patients with myomas larger than 10 cm after GnRHa administration (33{\%} vs 67{\%}, p =.001). In group A, there was a decrease in 2 or more myomas ≥ 5 cm (20{\%} vs 50{\%}) after GnRHa use. Group A also had significantly smaller mean myoma weight (448 vs 567 g, p =.045) and significantly shorter mean operative time (129 ± 30 vs 152 ± 34 minutes, p =.001). Most patients in group A (40{\%}) had an operative time < 119 minutes, whereas most patients in group B (37{\%}) had an operative time between 150 and 179 minutes. Group A also had less intraoperative blood loss (84 ± 53 vs 137 ± 166 mL, p <.001), drop in hemoglobin (1.5 ± 0.8 vs 3.0 ± 1.7 g/dl, p <.001), excessive bleeding (5{\%} vs 33{\%}, p =.001), postoperative hematoma (2.5{\%} vs 9.8{\%}, p =.168), and blood transfusion (7.5{\%} vs 35{\%}, p =.001). Conclusion: GnRHa before LM in large myomas may be an effective adjuvant treatment for women with large and multiple myomas. This method is beneficial in decreasing operative time, intraoperative bleeding, postoperative hemorrhage, and need of blood transfusion.",
keywords = "Gonadotropin-releasing hormone analogue, In situ morcellation, Laparoscopic myomectomy, Large myomas, Sarcoma",
author = "Chang, {Wen Chun} and Chu, {Ling Hui} and Huang, {Pei Shen} and Huang, {Su Cheng} and Sheu, {Bor Ching}",
year = "2015",
month = "1",
day = "1",
doi = "10.1016/j.jmig.2015.04.026",
language = "English",
volume = "22",
pages = "992--996",
journal = "Journal of Minimally Invasive Gynecology",
issn = "1553-4650",
publisher = "Elsevier",
number = "6",

}

TY - JOUR

T1 - Comparison of Laparoscopic Myomectomy in Large Myomas With and Without Leuprolide Acetate

AU - Chang, Wen Chun

AU - Chu, Ling Hui

AU - Huang, Pei Shen

AU - Huang, Su Cheng

AU - Sheu, Bor Ching

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Objective: To evaluate the efficacy of gonadotropin-releasing hormone analogue (GnRHa) use before laparoscopic myomectomy (LM) in large myomas. Design: Prospective study (Canadian Task Force classification II-1). Setting: University-affiliated hospital. Patients: Ninety-one women with large myomas (≥10 cm) or more than 2 myomas ≥ 5 cm underwent LM between July 2011 and March 2014. Interventions: Forty patients underwent LM after GnRHa use (group A) and 51 underwent LM only (group B). GnRHa was used for 3 doses every 4 weeks before LM in group A. Measurements and Main Results: Group A had a significantly smaller maximum diameter of the largest myoma than group B (8.5 ± 2.1 vs 10.7 ± 2.4, p <.001) and fewer patients with myomas larger than 10 cm after GnRHa administration (33% vs 67%, p =.001). In group A, there was a decrease in 2 or more myomas ≥ 5 cm (20% vs 50%) after GnRHa use. Group A also had significantly smaller mean myoma weight (448 vs 567 g, p =.045) and significantly shorter mean operative time (129 ± 30 vs 152 ± 34 minutes, p =.001). Most patients in group A (40%) had an operative time < 119 minutes, whereas most patients in group B (37%) had an operative time between 150 and 179 minutes. Group A also had less intraoperative blood loss (84 ± 53 vs 137 ± 166 mL, p <.001), drop in hemoglobin (1.5 ± 0.8 vs 3.0 ± 1.7 g/dl, p <.001), excessive bleeding (5% vs 33%, p =.001), postoperative hematoma (2.5% vs 9.8%, p =.168), and blood transfusion (7.5% vs 35%, p =.001). Conclusion: GnRHa before LM in large myomas may be an effective adjuvant treatment for women with large and multiple myomas. This method is beneficial in decreasing operative time, intraoperative bleeding, postoperative hemorrhage, and need of blood transfusion.

AB - Objective: To evaluate the efficacy of gonadotropin-releasing hormone analogue (GnRHa) use before laparoscopic myomectomy (LM) in large myomas. Design: Prospective study (Canadian Task Force classification II-1). Setting: University-affiliated hospital. Patients: Ninety-one women with large myomas (≥10 cm) or more than 2 myomas ≥ 5 cm underwent LM between July 2011 and March 2014. Interventions: Forty patients underwent LM after GnRHa use (group A) and 51 underwent LM only (group B). GnRHa was used for 3 doses every 4 weeks before LM in group A. Measurements and Main Results: Group A had a significantly smaller maximum diameter of the largest myoma than group B (8.5 ± 2.1 vs 10.7 ± 2.4, p <.001) and fewer patients with myomas larger than 10 cm after GnRHa administration (33% vs 67%, p =.001). In group A, there was a decrease in 2 or more myomas ≥ 5 cm (20% vs 50%) after GnRHa use. Group A also had significantly smaller mean myoma weight (448 vs 567 g, p =.045) and significantly shorter mean operative time (129 ± 30 vs 152 ± 34 minutes, p =.001). Most patients in group A (40%) had an operative time < 119 minutes, whereas most patients in group B (37%) had an operative time between 150 and 179 minutes. Group A also had less intraoperative blood loss (84 ± 53 vs 137 ± 166 mL, p <.001), drop in hemoglobin (1.5 ± 0.8 vs 3.0 ± 1.7 g/dl, p <.001), excessive bleeding (5% vs 33%, p =.001), postoperative hematoma (2.5% vs 9.8%, p =.168), and blood transfusion (7.5% vs 35%, p =.001). Conclusion: GnRHa before LM in large myomas may be an effective adjuvant treatment for women with large and multiple myomas. This method is beneficial in decreasing operative time, intraoperative bleeding, postoperative hemorrhage, and need of blood transfusion.

KW - Gonadotropin-releasing hormone analogue

KW - In situ morcellation

KW - Laparoscopic myomectomy

KW - Large myomas

KW - Sarcoma

UR - http://www.scopus.com/inward/record.url?scp=84953357214&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84953357214&partnerID=8YFLogxK

U2 - 10.1016/j.jmig.2015.04.026

DO - 10.1016/j.jmig.2015.04.026

M3 - Article

VL - 22

SP - 992

EP - 996

JO - Journal of Minimally Invasive Gynecology

JF - Journal of Minimally Invasive Gynecology

SN - 1553-4650

IS - 6

ER -